Trials / Terminated
TerminatedNCT02221154
Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Centre Hospitalier Departemental Vendee · Academic / Other
- Sex
- Female
- Age
- 18 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
The original mechanism of action of myo-inositol and preliminary results available in the literature on its use in IVF suggest its value as adjuvant gonadotropin therapy to reduce the risk of OHSS in PCOS patients. The aim of the study is to demonstrate that administration of myo-inositol decreases the incidence of ovarian hyperstimulation syndrome (OHSS) in high-risk infertile with PCOS supported in IVF patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Inofolic® | |
| OTHER | Gonadotropins; Folic Acid | standard ovarian stimulation |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2017-05-22
- Completion
- 2017-05-22
- First posted
- 2014-08-20
- Last updated
- 2017-06-16
Locations
4 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02221154. Inclusion in this directory is not an endorsement.